Published in N Engl J Med on April 22, 1993
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol (1997) 37.26
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol (1995) 15.19
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet (2010) 4.94
Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol (1993) 4.05
Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev (2006) 3.79
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns. Am J Respir Crit Care Med (2005) 3.75
Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A (1998) 3.22
Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol (1996) 2.91
IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J Clin Microbiol (1997) 2.54
Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun (2002) 2.35
Mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis compared to IS6110-based restriction fragment length polymorphism analysis for investigation of apparently clustered cases of tuberculosis. J Clin Microbiol (2003) 2.33
Specimen contamination in mycobacteriology laboratory detected by pseudo-outbreak of multidrug-resistant tuberculosis: analysis by routine epidemiology and confirmation by molecular technique. J Clin Microbiol (1996) 2.11
Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol (2000) 2.05
DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol (1995) 2.04
Evaluation of tuberculosis transmission in a community by 1 year of systematic typing of Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (1996) 2.03
A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis. Sci Transl Med (2010) 2.00
The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation. J Clin Microbiol (1999) 1.98
Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol (1995) 1.95
The past and future of tuberculosis research. PLoS Pathog (2009) 1.94
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol (2001) 1.66
Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun (1997) 1.48
Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J Immunol (2006) 1.47
False-positive results from cultures of Mycobacterium tuberculosis due to laboratory cross-contamination confirmed by restriction fragment length polymorphism. J Clin Microbiol (1997) 1.47
Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS One (2009) 1.43
Spoligotyping and polymorphic GC-rich repetitive sequence fingerprinting of mycobacterium tuberculosis strains having few copies of IS6110. J Clin Microbiol (2000) 1.37
Spoligotyping of Mycobacterium tuberculosis isolates from multiple-drug-resistant tuberculosis patients from Bombay, India. J Clin Microbiol (2002) 1.35
Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis. Emerg Infect Dis (2000) 1.35
Preparation of mycobacterial DNA from blood culture fluids by simple alkali wash and heat lysis method for PCR detection. J Clin Microbiol (1996) 1.34
The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link? Clin Exp Immunol (2006) 1.33
Rationale and methods for the National Tuberculosis Genotyping and Surveillance Network. Emerg Infect Dis (2002) 1.30
Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host. J Clin Microbiol (1999) 1.29
AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals. Thorax (1995) 1.26
Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. Emerg Infect Dis (2001) 1.24
Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun (1994) 1.22
Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis (2002) 1.21
Clinical latency and reactivation of AIDS-related mycobacterial infections. J Virol (2004) 1.19
The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect Dis (2008) 1.18
Mycobacterium tuberculosis--heterogeneity revealed through whole genome sequencing. Tuberculosis (Edinb) (2012) 1.17
Analysis of clonal composition of Mycobacterium tuberculosis isolates in primary infections in children. J Clin Microbiol (2004) 1.16
Differentiation of Mycobacterium tuberculosis complex and nontuberculous mycobacterial liquid cultures by using peptide nucleic acid-fluorescence In situ hybridization probes. J Clin Microbiol (2000) 1.15
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti. BMC Public Health (2006) 1.11
How molecular epidemiology has changed what we know about tuberculosis. West J Med (2000) 1.10
Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci U S A (1995) 1.10
Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. Tuberculosis (Edinb) (2011) 1.09
Distinctiveness of Mycobacterium tuberculosis genotypes from human immunodeficiency virus type 1-seropositive and -seronegative patients in Lima, Peru. J Clin Microbiol (2003) 1.08
Alcohol exacerbates murine pulmonary tuberculosis. Infect Immun (2004) 1.08
Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting. J Clin Microbiol (2003) 1.06
Determinants of cluster distribution in the molecular epidemiology of tuberculosis. Proc Natl Acad Sci U S A (2002) 1.05
When tuberculosis comes back: who develops recurrent tuberculosis in california? PLoS One (2011) 1.05
Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-year period (1993 to 1995) in Seville, Spain. J Clin Microbiol (1997) 1.02
Drug-resistant tuberculosis. CMAJ (2000) 1.01
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001-2003. Epidemiol Infect (2006) 1.00
Genetic fingerprinting in the study of tuberculosis transmission. CMAJ (1999) 0.99
Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches. Cold Spring Harb Perspect Med (2014) 0.98
Guinea pig model of Mycobacterium tuberculosis latent/dormant infection. Microbes Infect (2008) 0.98
Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis (2012) 0.97
Mycobacterium tuberculosis transmission between cluster members with similar fingerprint patterns. Emerg Infect Dis (2002) 0.97
Mixed tuberculosis infections in rural South Vietnam. J Clin Microbiol (2012) 0.95
The dynamics of repeated elements: applications to the epidemiology of tuberculosis. Proc Natl Acad Sci U S A (2000) 0.94
Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994. Public Health Rep (1999) 0.93
Tuberculosis: 8. The disease in association with HIV infection. CMAJ (1999) 0.92
Detection and identification of mycobacteria by amplification of RNA and DNA in pretreated blood and bone marrow aspirates by a simple lysis method. J Clin Microbiol (1997) 0.92
Evaluation and utilization as a public health tool of a national molecular epidemiological tuberculosis outbreak database within the United Kingdom from 1997 to 2001. J Clin Microbiol (2003) 0.92
Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis. PLoS One (2014) 0.92
Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC Infect Dis (2014) 0.92
Dysregulated production of interleukin-8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis. Infect Immun (1999) 0.91
Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006. Clin Infect Dis (2012) 0.91
Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol (1994) 0.90
Epidemiology of tuberculosis on Gran Canaria: a 4 year population study using traditional and molecular approaches. Thorax (2003) 0.90
Nosocomial transmission of tuberculosis in HIV/AIDS units in London. Genitourin Med (1997) 0.90
Recurrent tuberculosis: relapse, reinfection, and HIV. J Infect Dis (2010) 0.90
Partial reconstitution of the CD4+-T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines. Infect Immun (2006) 0.89
Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health (2011) 0.89
Within-host dynamics of multi-species infections: facilitation, competition and virulence. PLoS One (2012) 0.89
Recent advances in our understanding of human host responses to tuberculosis. Respir Res (2001) 0.86
A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8+ T-cell immune response in South African patients with active tuberculosis. PLoS One (2013) 0.85
Restriction fragment length polymorphism typing of Mycobacterium tuberculosis. Thorax (1995) 0.82
Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration. Int J Tuberc Lung Dis (2000) 0.81
Secondary typing of Mycobacterium tuberculosis isolates with matching IS6110 fingerprints from different geographic regions of the United States. J Clin Microbiol (2001) 0.80
HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data. PLoS One (2012) 0.80
HIV infection and sputum-culture conversion in patients diagnosed with Mycobacterium tuberculosis: a population-based study. Wien Klin Wochenschr (2003) 0.80
Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife (2016) 0.80
Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas. Prof Geogr (2008) 0.80
Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB. PLoS One (2010) 0.79
Oligonucleotide (GTG)5 as an epidemiological tool in the study of nontuberculous mycobacteria. J Clin Microbiol (1997) 0.79
Novel hot spot of IS6110 insertion in Mycobacterium tuberculosis. J Clin Microbiol (2010) 0.78
A tale of two mutants. N Engl J Med (1993) 0.76
Comparison of restriction fragment length polymorphism with the polymorphic guanine-cytosine-rich sequence and spoligotyping for differentiation of Mycobacterium tuberculosis isolates with five or fewer copies of IS6110. J Clin Microbiol (2009) 0.76
Comparative Analysis of Human B Cell Epitopes Based on BCG Genomes. Biomed Res Int (2016) 0.75
Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis. Respirology (2012) 0.75
Reinfection with multidrug-resistant tuberculosis. N Engl J Med (1993) 0.75
Reinfection with multidrug-resistant tuberculosis. N Engl J Med (1993) 0.75
Resistance to Antituberculosis Drugs in Pulmonary Tuberculosis. Med J Armed Forces India (2011) 0.75
Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science (1999) 17.48
The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med (1994) 16.32
An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med (1992) 13.29
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet (1999) 10.06
Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J (2001) 7.73
Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A (2001) 7.65
An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science (1991) 6.25
Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci U S A (1999) 5.76
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66
Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest (1976) 5.54
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science (1998) 5.49
Total silencing by intron-spliced hairpin RNAs. Nature (2000) 4.78
The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med (1984) 4.46
Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci U S A (1999) 4.33
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis (1987) 4.11
Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol (1993) 4.05
Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis (1998) 3.89
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med (1995) 3.80
Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) (2004) 3.70
Detection of Shigella in feces using DNA amplification. J Infect Dis (1990) 3.61
Control strategies for tuberculosis epidemics: new models for old problems. Science (1996) 3.59
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med (1992) 3.39
Gonococcal pili. Primary structure and receptor binding domain. J Exp Med (1984) 3.32
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med (1999) 3.26
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J Virol (1996) 3.21
Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 3.17
Cloning and characterization of bfpTVW, genes required for the transcriptional activation of bfpA in enteropathogenic Escherichia coli. Mol Microbiol (1996) 2.96
Propagation of Pneumocystis carinii in vitro. Pediatr Res (1977) 2.92
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 2.92
A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors. J Clin Invest (1998) 2.88
Study on clinico-epidemiological profile of HIV patients in eastern India. J Assoc Physicians India (2006) 2.87
VpsR, a Member of the Response Regulators of the Two-Component Regulatory Systems, Is Required for Expression of vps Biosynthesis Genes and EPS(ETr)-Associated Phenotypes in Vibrio cholerae O1 El Tor. J Bacteriol (2001) 2.77
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Strain-specific and common epitopes of gonococcal pili. J Exp Med (1984) 2.72
Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet (1987) 2.68
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2009) 2.68
Multi-gene amplification: simultaneous detection of three virulence genes in diarrhoeal stool. Mol Microbiol (1989) 2.65
Role of rpoS in stress survival and virulence of Vibrio cholerae. J Bacteriol (1998) 2.65
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol (2009) 2.60
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2011) 2.50
Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J (1989) 2.38
Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults. Am J Med (1981) 2.36
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Ann Intern Med (1999) 2.36
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.36
Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis (1998) 2.35
Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol (1993) 2.35
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health (2009) 2.35
The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet (1996) 2.35
Ultrastructural localization of specific gonococcal macromolecules with antibody-gold sphere immunological probes. Infect Immun (1984) 2.31
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients. J Infect Dis (1993) 2.28
Mannose-sensitive and Gal-Gal binding Escherichia coli pili from recombinant strains. Chemical, functional, and serological properties. J Exp Med (1983) 2.27
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
A pilus peptide vaccine for the prevention of gonorrhea. Prog Allergy (1983) 2.19
T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis (2009) 2.19
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs. Nucleic Acids Res (2001) 2.13
The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA (2000) 2.12
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis (1987) 2.09
The bundle-forming pili of enteropathogenic Escherichia coli: transcriptional regulation by environmental signals. Mol Microbiol (1996) 2.08
Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J Bacteriol (1996) 2.08
Genetic studies on Neisseria gonorrhoeae from disseminated gonococcal infections. Infect Immun (1977) 2.08
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
Subacute arsenic neuropathy: clinical and electrophysiological observations. J Neurol Neurosurg Psychiatry (1981) 2.05
Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis (2000) 2.04
Mycobacteria and AIDS mortality. Am Rev Respir Dis (1989) 2.02
A systematic review and meta-regression analysis of aggression during the first episode of psychosis. Acta Psychiatr Scand (2013) 2.01
Demonstration of pulmonary arteries by contrast injection into pulmonary vein. Br Heart J (1978) 1.99
Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid. Infect Immun (1999) 1.98
Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J Infect Dis (2001) 1.97
Pneumocystis carinii in vitro: A study by scanning electron microscopy. Am J Pathol (1977) 1.96
Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India. Am J Trop Med Hyg (2005) 1.96
Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol (1994) 1.95
Patients with suspected myocardial infarction: effect of mode of referral on admission time to a coronary care unit. Br J Gen Pract (1992) 1.92
Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (1997) 1.92
Unique sequences in region VI of the flagellin gene of Salmonella typhi. Mol Microbiol (1989) 1.90
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89
Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA (2000) 1.88
Fractures of the tibial tuberosity in adolescents. J Bone Joint Surg Am (1980) 1.88
Localized adherence by enteropathogenic Escherichia coli is an inducible phenotype associated with the expression of new outer membrane proteins. J Exp Med (1991) 1.87
Patterns and predictors of hospitalisation in first-episode psychosis. Prospective cohort study. Br J Psychiatry (2001) 1.87
Pilin-gene phase variation of Moraxella bovis is caused by an inversion of the pilin genes. J Bacteriol (1988) 1.86
Sequence, localization and function of the invasin protein of Yersinia enterocolitica. Mol Microbiol (1990) 1.84
Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. I. The Escherichia coli hemoflavoprotein: molecular parameters and prosthetic groups. J Biol Chem (1973) 1.82
Three-dimensional structure of cholera toxin penetrating a lipid membrane. Science (1988) 1.81
The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J Cell Biol (1992) 1.81
The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg (1997) 1.79
HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature (1988) 1.78
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int (1995) 1.74
Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med (2000) 1.71
Cloning and characterization of the bundle-forming pilin gene of enteropathogenic Escherichia coli and its distribution in Salmonella serotypes. Mol Microbiol (1993) 1.71